Koala, SpaceX, Eli Lilly, Nike, Anthropic & Pimp my Portfolio with Owen Rask

This episode of the Equity Mates Investing Podcast dives into a range of global market developments, starting with the recent IPO of Australian furniture brand Koala, which surged on debut, and the highly anticipated confidential IPO filing of SpaceX, valued at $1.75 trillion and poised to be the largest in history. The discussion then shifts to Eli Lilly’s approval of its once-daily weight loss pill, Foundayo, which could significantly expand the GLP-1 drug market. In contrast, Nike faces a 16% single-day drop due to a forecasted 20% revenue decline in China, highlighting ongoing challenges in its direct-to-consumer strategy. The episode also covers a major security incident at Anthropic, where the source code for its AI tool Claude Code was accidentally leaked on GitHub, raising concerns about intellectual property and competitive advantage. The hosts emphasize the importance of long-term investing amid geopolitical uncertainty, using historical market data to illustrate how missing the best days can drastically reduce returns. They advocate for dollar-cost averaging, financial discipline, and portfolio resilience. The episode concludes with a 'Pimp My Portfolio' segment featuring John’s portfolio, which is heavily weighted toward ANZ shares due to past employment, with Owen Rask offering thoughtful feedback on diversification, risk exposure, and the strategic role of gold and fixed-income ETFs like QAU. Owen encourages gradual rebalancing, maintaining a balanced asset allocation, and preparing for any market scenario, not just predictable ones.